active

Artios

11801198 First deal Sept 2016

Deals

£223M

Total Capital Raised/Funded

Deal History

VC Funding Series D+ 17 Nov 2025

Investor: Novartis Venture Fund, Sofinnova Partners, SV Health Investors, Omega Funds, Pfizer Ventures, Invus, RA Capital Management, M Ventures, Janus Henderson Investors, Avidity Partners, Piper Heartland Healthcare Capital, RA Capital Management, EQT Life Sciences, Andera Partners, Schroders Capital

£87M

VC Funding Series C 27 Jul 2021

Investor: CaaS Capital Management, Omega Funds, Tetragon Financial Group Limited, Schroders Capital, Piper Heartland Healthcare Capital, Avidity Partners, Sofinnova Partners, Soleus Capital, Invus, Deep Track Capital, TCG X, RTW Investments LP

£111M

VC Funding Series A 1 Sept 2016

Investor: Imperial Innovations Limited, Abbvie Biotech Ventures, SV Life Sciences

£25M

Funding Timeline

September 2016

VC Funding Series A £25M

Imperial Innovations Limited, Abbvie Biotech Ventures, SV Life Sciences

July 2021

VC Funding Series C £111M

CaaS Capital Management, Omega Funds, Tetragon Financial Group Limited, Schroders Capital, Piper Heartland Healthcare Capital, Avidity Partners, Sofinnova Partners, Soleus Capital, Invus, Deep Track Capital, TCG X, RTW Investments LP

November 2025

VC Funding Series D+ £87M

Novartis Venture Fund, Sofinnova Partners, SV Health Investors, Omega Funds, Pfizer Ventures, Invus, RA Capital Management, M Ventures, Janus Henderson Investors, Avidity Partners, Piper Heartland Healthcare Capital, RA Capital Management, EQT Life Sciences, Andera Partners, Schroders Capital

Financial History

Directors & Officers

Companies House